---
figid: PMC8891816__gr2
figtitle: 'miR-221/222 as biomarkers and targets for therapeutic intervention on cancer
  and other diseases: A systematic review'
organisms:
- Human papillomavirus
- Human papillomavirus type 16
- Adeno-associated virus
- Theobroma cacao
- Allium sativum
- Citrus deliciosa
- Homo sapiens
- Mus musculus
- Rattus norvegicus
- Pseudomonas aeruginosa
- Helicobacter pylori
- Macaca fascicularis
- Danio rerio
- Canis lupus familiaris
- NA
organisms_ner:
- Mus musculus
- Rattus norvegicus
- Canis lupus familiaris
- Homo sapiens
- Macaca fascicularis
- Danio rerio
- Drosophila melanogaster
pmcid: PMC8891816
filename: gr2.jpg
figlink: /pmc/articles/PMC8891816/figure/fig2/
number: F2
caption: MiRNA-221 activity in HER2+ and Luminal BC(A) miR-221 targets PI3K-AKT-mTOR
  pathway in HER2+ BC. When PTEN works correctly, it helps to control the cell cycle,
  but when it is not functioning at full speed, cells multiply in an uncontrolled
  way, turning into tumor formations. PTEN inhibits the PI3K-AKT-mTOR pathway downstream
  of HER2, leading to resistance to various therapies like CDK 4/6 inhibitors. miR-221
  facilitates tumor proliferation downregulating PTEN thus inducing EMT. miR-221 downregulates
  PTEN, thus inducing EMT. (B) miR-221 promotes hormonal resistance in luminal BC.
  IL6/Stat3 pathway drives the proliferation of CAFs and production of oncomiR-221
  MVs. MVs horizontally transfer miR-221. miR-221 promotes conversion of non-CSC (ER
  high) into therapy-resistant CSC (ER low) by Notch3 upregulation and ER signaling
  suppression. This leads to CD133hi/ERlo/Notch hi CSCs.
papertitle: 'miR-221/222 as biomarkers and targets for therapeutic intervention on
  cancer and other diseases: A systematic review.'
reftext: Maria Teresa Di Martino, et al. Mol Ther Nucleic Acids. 2022 Mar 8;27:1191-1224.
year: '2022'
doi: 10.1016/j.omtn.2022.02.005
journal_title: Molecular Therapy. Nucleic Acids
journal_nlm_ta: Mol Ther Nucleic Acids
publisher_name: American Society of Gene & Cell Therapy
keywords: miR-221 | miR-221/222 | miRs | miR | microRNA | miR therapeutics | cancer
  | NASH | sarcomas | myeloma | breast cancer | gastrointestinal cancer | lung cancer
  | hepatocellular carcinoma | ovarian cancer | cervical cancer | endometrial cancer
  | pancreatic cancer | biliary tract cancer | prostate cancer | glioblastoma | urogenital
  cancer | bladder cancer | renal cell carcinoma | gynecological cancers | melanoma
  | solid cancers | hematological diseases | neuropathy | demyelinating diseases |
  pharmacokinetics
automl_pathway: 0.9361031
figid_alias: PMC8891816__F2
figtype: Figure
redirect_from: /figures/PMC8891816__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8891816__gr2.html
  '@type': Dataset
  description: MiRNA-221 activity in HER2+ and Luminal BC(A) miR-221 targets PI3K-AKT-mTOR
    pathway in HER2+ BC. When PTEN works correctly, it helps to control the cell cycle,
    but when it is not functioning at full speed, cells multiply in an uncontrolled
    way, turning into tumor formations. PTEN inhibits the PI3K-AKT-mTOR pathway downstream
    of HER2, leading to resistance to various therapies like CDK 4/6 inhibitors. miR-221
    facilitates tumor proliferation downregulating PTEN thus inducing EMT. miR-221
    downregulates PTEN, thus inducing EMT. (B) miR-221 promotes hormonal resistance
    in luminal BC. IL6/Stat3 pathway drives the proliferation of CAFs and production
    of oncomiR-221 MVs. MVs horizontally transfer miR-221. miR-221 promotes conversion
    of non-CSC (ER high) into therapy-resistant CSC (ER low) by Notch3 upregulation
    and ER signaling suppression. This leads to CD133hi/ERlo/Notch hi CSCs.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Cdk1
  - Gabrg2
  - Cdk2
  - Caf
  - Map6
  - Stat3
  - Il6
  - Mir221
  - Mv
  - Cdk6
  - Cdk4
  - Pik3r1
  - Hts
  - Akt1
  - Mtor
  - Esr1
  - Eral1
  - Pten
  - Prom1
  - htr
  - Ldha
  - Defb1
  - Pik3cg
  - Atp7b
  - Notch1
  - CDK1
  - CDK2
  - STAT3
  - IL6
  - MIR221
  - CDK6
  - CDK4
  - MTOR
  - ESR1
  - PTEN
  - WARS1
  - KAT2B
  - MAP6
  - E2F1
  - E2F2
  - E2F3
  - E2F4
  - E2F5
  - E2F6
  - E2F7
  - E2F8
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - APCDD1
  - AKT1
  - AKT2
  - AKT3
  - NOTCH1
  - NOTCH2
  - NOTCH3
  - NOTCH4
  - ERAL1
  - PROM1
  - F2R
  - TERC
  - HTR3A
  - HTR3B
  - HTR3C
  - HTR3D
  - HTR3E
  - HTR4
  - HTR6
  - HTR7
  - HTR1A
  - HTR1B
  - HTR1D
  - HTR1E
  - HTR2A
  - HTR2B
  - HTR2C
  - cdk1
  - cdk2
  - stat3
  - il6
  - dre-mir-221
  - cdk6
  - cdk4
  - mtor
  - esr1
  - ptenb
  - anon-70Dc
  - Acf
  - LanB2
  - anon-70Db
  - stop
  - ebi
  - E2f2
  - E2f1
  - rb
  - mv
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - hts
  - Akt
  - Tor
  - .na.character
  - era
---
